Cryopreservation of human lymphocytes for assessment of lymphocyte subsets and natural killer cytotoxicity.
Cryopreservation of lymphocytes has become increasingly important, especially when the cells are to be used in retrospective studies of selected and dwindling populations, such as A-bomb survivors. This report describes an efficient method for cryopreservation of human lymphocytes which does not significantly alter various immunological characteristics of these cells. The proportions of Leu-1+ cells (T cells), Leu-2a+ cells (suppressor-cytotoxic T cells), Leu-3a+ cells (helper-inducer T cells), HLA-DR+ cells, Mo2+ cells (monocytes), B1+ cells (B cells), and Leu-7+ cells (natural killer (NK) cells), as determined by monoclonal antibodies, were found to be stable following cryopreservation. NK cell activity against K-562 target cells showed a 40-60% decrease immediately after thawing, but recovered to approximate pre-freezing levels after preincubation for 18 h. Neither lymphocyte subsets nor cell viability significantly changed following preincubation after cryopreservation. However, the ratio of cells binding to K-562 cells increased after this preincubation and may account for the observed recovery of NK cell activity. NK cell activity remained relatively stable up to 14 months of storage which confirms that freezing damage depends on the freezing process rather than on the duration of cryopreservation.
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface / Q000032:analysis; D003602:Cytotoxicity, Immunologic; D004306:Dose-Response Relationship, Immunologic; D005615:Freezing; D006801:Humans; D007113:Immunity, Innate; D007694:Killer Cells, Natural / Q000276:immunology; D008214:Lymphocytes / Q000145:classification / Q000502:physiology*; D011309:Preservation, Biological; D013997:Time Factors
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface